The estimated Net Worth of Suresh K. Durgam is at least 5.51 百万$ dollars as of 7 March 2024. Dr Durgam owns over 10,162 units of Intra-Cellular Therapies Inc stock worth over 1,479,680$ and over the last 4 years he sold ITCI stock worth over 3,302,822$. In addition, he makes 730,360$ as Sr. VP & Chief Medical Officer at Intra-Cellular Therapies Inc.
Dr has made over 17 trades of the Intra-Cellular Therapies Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 10,162 units of ITCI stock worth 672,826$ on 7 March 2024.
The largest trade he's ever made was exercising 62,282 units of Intra-Cellular Therapies Inc stock on 2 January 2024 worth over 1,237,543$. On average, Dr trades about 10,067 units every 55 days since 2021. As of 7 March 2024 he still owns at least 19,803 units of Intra-Cellular Therapies Inc stock.
You can see the complete history of Dr Durgam stock trades at the bottom of the page.
Dr. Suresh K. Durgam M.D. is the Sr. VP & Chief Medical Officer at Intra-Cellular Therapies Inc.
As the Sr. VP & Chief Medical Officer of Intra-Cellular Therapies Inc, the total compensation of Dr D at Intra-Cellular Therapies Inc is 730,360$. There are 9 executives at Intra-Cellular Therapies Inc getting paid more, with Sharon Mates having the highest compensation of 4,724,560$.
Dr D is 52, he's been the Sr. VP & Chief Medical Officer of Intra-Cellular Therapies Inc since . There are 13 older and 3 younger executives at Intra-Cellular Therapies Inc. The oldest executive at Intra-Cellular Therapies Inc is Richard Lerner, 81, who is the Independent Director.
Suresh's mailing address filed with the SEC is C/O INTRA-CELLULAR THERAPIES, INC., 430 EAST 29TH STREET, NEW YORK, NY, 10016.
Over the last 11 years, insiders at Intra-Cellular Therapies Inc have traded over 77,703,646$ worth of Intra-Cellular Therapies Inc stock and bought 3,068,522 units worth 52,322,638$ . The most active insiders traders include Rory B Riggs、Joel S Marcus、Christopher D Alafi. On average, Intra-Cellular Therapies Inc executives and independent directors trade stock every 17 days with the average trade being worth of 2,787,280$. The most recent stock trade was executed by Sharon Mates on 29 August 2024, trading 70,000 units of ITCI stock currently worth 891,100$.
intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.
Intra-Cellular Therapies Inc executives and other stock owners filed with the SEC include: